Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes

Cell Death and Disease

Volumn 5, Issue , 2014, Pages

  Colasanti, T ^a,b   Vomero, M ^a   Alessandri, C ^c   Barbati, C ^a,d   Maselli, A ^a   Camperio, C ^c   Conti, F ^c   Tinari, A ^a   Carlo Stella, C ^e,f   Tuosto, L ^c   Benincasa, D ^g,h   Valesini, G ^c   Malorni, W ^a,d   Pierdominici, M ^a   Ortona, E ^a,d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b San Raffaele   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d San Raffaele Institute Sulmona   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

autophagy; lymphoma; systemic lupus erythematosus; T lymphocytes; synuclein

Indexed keywords

3 METHYLADENINE; ALPHA SYNUCLEIN; AUTOPHAGY PROTEIN 5; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; PROTEIN P62; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; SNCA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL LEVEL; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; MOLECULAR WEIGHT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UPREGULATION; CLINICAL TRIAL; GENETICS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALPHA-SYNUCLEIN; AUTOPHAGY; BIOLOGICAL MARKERS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 84924249398     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.211     Document Type: Article

References (39)

1. Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 2013; 14: 38-48.
2. Kim S, Jeon BS, Heo C, Im PS, Ahn TB, Seo JH et al. Alpha-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease. FASEB J 2004; 18: 1615-1617.
3. Shin EC, Cho SE, Lee DK, Hur MW, Paik SR, Park JH et al. Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages. Mol Cells 2000; 10: 65-70.
4. Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE. Alpha-synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol 2013; 73: 155-169.
5. Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L. Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol 2011; 10: 1015-1025.
6. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8: 931-937.
7. Mizushima N, Klionsky DJ. Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 2007; 27: 19-40.
8. Engelender S. Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease. Autophagy 2008; 4: 372-374.
9. Martinez-Vicente M, Vila M. Alpha-synuclein and protein degradation pathways in Parkinson's disease: a pathological feed-back loop. Exp Neurol 2013; 247: 308-313.
10. Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA et al. Alpha-synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 2010; 190: 1023-1037.
11. McLeod IX, Jia W, He YW. The contribution of autophagy to lymphocyte survival and homeostasis. Immunol Rev 2012; 249: 195-204.
12. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469: 323-335.
13. Pierdominici M, Vomero M, Barbati C, Colasanti T, Maselli A, Vacirca D et al. Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus. FASEB J 2012; 26: 1400-1412.
14. Zhou XJ, Zhang H. Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases. Autophagy 2012; 8: 1286-1299.
15. Ma Y, Galluzzi L, Zitvogel L, Kroemer G. Autophagy and cellular immune responses. Immunity 2013; 39: 211-227.
16. Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M et al. T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J 2012; 26: 4722-4732.
17. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007; 3: 542-545.
18. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544.
19. Bellucci A, Collo G, Sarnico I, Battistin L, Missale C, Spano P. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation. J Neurochem 2008; 106: 560-577.
20. Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW et al. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 2011; 7: 1159-1172.
21. Guidetti A, Carlo-Stella C, Locatelli SL, Malorni W, Pierdominici M, Barbati C et al. Phase II study of sorafenib in patients with relapsed or refractory lymphoma. Br J Haematol 2012; 158: 108-119.
22. Manzoni C, Lewis PA. Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies. FASEB J 2013; 27: 3424-3429.
23. Gerland LM, Genestier L, Peyrol S, Michallet MC, Hayette S, Urbanowicz I et al. Autolysosomes accumulate during in vitro CD8+ T-lymphocyte aging and may participate in induced death sensitization of senescent cells. Exp Gerontol 2004; 39: 789-800.
24. Phadwal K, Alegre-Abarrategui J, Watson AS, Pike L, Anbalagan S, Hammond EM et al. A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells. Autophagy 2012; 8: 677-689.
25. He MX, He YW. A role for c-FLIP(L) in the regulation of apoptosis, autophagy, and necroptosis in T lymphocytes. Cell Death Differ 2013; 20: 188-197.
26. Song JX, Lu JH, Liu LF, Chen LL, Durairajan SS, Yue Z et al. HMGB1 is involved in autophagy inhibition caused by SNCA/alpha-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B. Autophagy 2013; 10: 144-154.
27. Huang J, Liu K, Yu Y, Xie M, Kang R, Vernon P et al. Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy 2012; 8: 275-277.
28. Djavaheri-Mergny M, Maiuri MC, Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 2010; 29: 1717-1719.
29. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009; 16: 966-975.
30. Nagy G, Koncz A, Perl A. T- and B-cell abnormalities in systemic lupus erythematosus. Crit Rev Immunol 2005; 25: 123-140.
31. Fernandez D, Bonilla E, Mirza N, Niland B, Perl A. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2983-2988.
32. Leslie LA, Younes A. Targeting oncogenic and epigenetic survival pathways in lymphoma. Leuk Lymphoma 2013; 54: 2365-2376.
33. Masuda M, Suzuki N, Taniguchi S, Oikawa T, Nonaka T, Iwatsubo T et al. Small molecule inhibitors of alpha-synuclein filament assembly. Biochemistry 2006; 45: 6085-6094.
34. Singh PK, Kotia V, Ghosh D, Mohite GM, Kumar A, Maji SK. Curcumin modulates alpha-synuclein aggregation and toxicity. ACS Chem Neurosci 2013; 4: 393-407.
35. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
36. Habig K, Walter M, Stappert H, Riess O, Bonin M. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA - a key player in the pathogenesis of Parkinson's disease. Brain Res 2009; 1256: 19-33.
37. Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C et al. Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum 2012; 64: 778-787.
38. Lee BR, Kamitani T. Improved immunodetection of endogenous alpha-synuclein. PLoS One 2011; 6: e23939.
39. Gros F, Arnold J, Page N, Decossas M, Korganow AS, Martin T et al. Macroautophagy is deregulated in murine and human lupus T lymphocytes. Autophagy 2012; 8: 1113-1123.